Top 50 Life Science Startup Investors in Spain (November 2026)

Portfolio highlights

• EpiDisease — EpiDisease provides biomedical solutions, epigenetic diagnostic tools, and characterization of new epigenetic drugs. The company was founded in 2014 and based in Paterna, Comunidad Valenciana, Spain.
• Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
• Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.

Portfolio highlights

• FlexiiC — Reinventing the world of electronics with a revolutionary organic and flexible technology that enables a new generation of sensors and logic based on solution deposited functional inks at a low temperature, on low-cost substrates to make organic integrated circuits. Products and services FlexiiC presents design modeling services including Application Specific Integrated Circuits (ASIC) and Process ... Read more
• Bioherent — Photonic biosensors for drug allergy diagnosis
• Impetux Optics — Optical tweezers and microscopy systems for Cell Mechanics, Molecular Biophysics, Phase Separation and Soft Matter Physics applications

Portfolio highlights

• Safeloc Systems — Safeloc Systems is a developer of a real-time location system solution (RTLS) to provide ultra-wideband (UWB) technology services.
• Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
• Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.

Portfolio highlights

• AbTx — Antibody for Therapy
• DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
• EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.

Portfolio highlights

• Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
• ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
• Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.

Portfolio highlights

• ALLOX — ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery. The company combines high-throughput genetics, experimental biology, computational biology, and machine learning to identify functional regions in proteins, including allosteric sites that regulate protein activity. Its proprietary platform uses systematic mutagenesis to measure how thousands of genetic mutations affect protein function, structure, and interactions. These experimental datasets provide the foundation for computational models that predict potential therapeutic targets and guide the design of small-molecule drugs. ALLOX focuses on discovering druggable sites in proteins that have historically been difficult to target, including protein-protein interactions and transcription factors. Its initial research programs focus on oncology, with potential applications across other disease areas. The company also develops its own drug discovery pipeline and collaborates with pharmaceutical and biotechnology partners on research programs. ALLOX originated as a spin-off from the Centre for Genomic Regulation and applies its platform to the discovery of new therapeutic approaches for diseases with limited treatment options.
• Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.

Portfolio highlights

• ALLOX — ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery. The company combines high-throughput genetics, experimental biology, computational biology, and machine learning to identify functional regions in proteins, including allosteric sites that regulate protein activity. Its proprietary platform uses systematic mutagenesis to measure how thousands of genetic mutations affect protein function, structure, and interactions. These experimental datasets provide the foundation for computational models that predict potential therapeutic targets and guide the design of small-molecule drugs. ALLOX focuses on discovering druggable sites in proteins that have historically been difficult to target, including protein-protein interactions and transcription factors. Its initial research programs focus on oncology, with potential applications across other disease areas. The company also develops its own drug discovery pipeline and collaborates with pharmaceutical and biotechnology partners on research programs. ALLOX originated as a spin-off from the Centre for Genomic Regulation and applies its platform to the discovery of new therapeutic approaches for diseases with limited treatment options.
• Bomaq — bomaq manufactures and distributes rough-terrain and four-wheel-drive forklift trucks for material-handling applications. Its product range includes Multi Purpose models with lifting capacities from 3 to 10 tons, as well as customized machines adapted with different cabins, masts, hydraulic configurations, and other options. The equipment is used in sectors such as construction, agriculture, mining, recycling, military operations, timber, and public works. Bomaq also provides after-sales documentation, spare parts, maintenance information, technical support, dealer training, and online training. The company is developing an electric rough-terrain forklift with four-wheel drive and a 2.5-ton lifting capacity.
• Optare Solutions — System Integrator working for Telecom companies worldwide since 2002

Portfolio highlights

• Mirai RiskTech — AI-driven balance sheet management for banks: ALM and liquidity, FTP, and regulatory reporting on one data model.
• Blinker — Blinker specializes in the wholesale of hardware.
• Fastbase Solutions — Fastbase is to be the platform in cancer diagnostics, bringing precision to cancer patient treatment. This will enable solution of the current problems, which lie in precisely targeting therapies to disease drivers. Fastbase provides a fast and efficient platform technology to measure drug target function. The benefits of precision medicine thatcan be provided by Fastbase would be to deliver treatment to patients selected to respond to therapy, stop the treatment of patients who will not respond, improve patient outcomes and quality of life and also reduce drug costs. Fastbase will be a major player for collaborative opportunities with European Health system.

Portfolio highlights

• Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
• MiMARK — MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
• Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.

Portfolio highlights

• Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
• Pekata — Pekata offers technological solution that allows employee to customize hamper based on personal tastes, dietary restrictions.
• DARWIN Biomed — Biomedical Engineering

Portfolio highlights

• Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
• X1 Wind — X1 Wind is a disruptive innovative floating wind platform with the potential to make a step change in offshore wind.
• Flavii Therapeutics — Flavii Therapeutics is a biotechnology company that develops epigenetic therapies for central nervous system disorders with high unmet medical need. Flavii’s lead program, FLVA-27, is a first-in-class small-molecule inhibitor of G9a, a key epigenetic regulator of brain function. FLVA-27 demonstrates exceptional brain penetration, favorable PK/PD properties, and a robust safety profile.

Portfolio highlights

• Basquevolt — Basquevolt is a leader in solid state battery technology.
• FYLA — FYLA designs ultrafast fiber lasers, combining precision engineering and quality. Discover supercontinuum and femtosecond laser solutions.
• A4CELL — A4CELL is a company that develops SPAchip (suspended planar-array chips) that help monitor living single cells. They offer SPAchips, as well as the CytoCHECK SPAchip and the CytoCHECK SPAchip. The company's goal is to increase the accuracy and quality of cell study data in order to better understand disease behavior.

Portfolio highlights

• Remolon — Remolon's mission is to reduce food losses and waste while also building a better food system for all.
• Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
• Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.

Portfolio highlights

• DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
• Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.

Portfolio highlights

• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
• Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
• TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Portfolio highlights

• AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
• Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
• Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).

Portfolio highlights

• Hair Up Laser — Making alopecia a problem of the past.
• Flavii Therapeutics — Flavii Therapeutics is a biotechnology company that develops epigenetic therapies for central nervous system disorders with high unmet medical need. Flavii’s lead program, FLVA-27, is a first-in-class small-molecule inhibitor of G9a, a key epigenetic regulator of brain function. FLVA-27 demonstrates exceptional brain penetration, favorable PK/PD properties, and a robust safety profile.
• Onalabs Inno-hub — Onalabs develops remote, continuous and non-invasive bio-medical devices to monitor through the skin and sweat several vital signs and some biomarkers. Onalabs is the first non-invasive device able to measure some chemical parameters present in sweat using miniaturised biosensors. Its non-invasive products based on wearable formats empower thepatients and their families to measure relevant vital signs and biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. The solutions are addressed to chronic patients, such as COPD, HF and Diabetes.

Portfolio highlights

• Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
• VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
• Iteria Biopharma — PROFESSIONAL TEAM User can utilize his smartphone to pay for a wide range of services or any CONSULTATION User can utilize his smartphone to pay for a wide range of services or any TREATMENT User can utilize his smartphone to pay for a wide range of services or any First-in-class NCEs addressed to modulate challenging

Portfolio highlights

• TietAI — TietAI is the agentic integration layer for hospitals, payers and digital health, unifying HL7, FHIR, X12 and DICOM into one governed plane.
• Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
• Kompanion — Kompanion operates a specialized back-office platform that unifies accounting, payroll, and tax operations in real time for startups, ecommerce entities, and digital agencies. The company combines its proprietary technology with an expert advisory team to manage administrative compliance, financial tracking, and labor documentation. Its value proposition centers on eliminating manual data entry and traditional corporate advisory delays by providing automated onboarding and rapid digital communication.

Portfolio highlights

• PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
• Oncovision — Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology.They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases.Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide.Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience.With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.
• Atlas Molecular Pharma — Latest News Your browser does not support the video tag.

Portfolio highlights

• NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
• Adaptam Therapeutics — Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
• Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.

Portfolio highlights

• Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
• Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
• Thred — The AI-native power dialer reps make their own. Intelligent anti-spam, personalized AI texts and voicemail drops, rep-designed workflows, and ICP-filtered website leads.

Portfolio highlights

• Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
• Frontier Computing — Frontier Computing is a biocomputing company growing large-scale neuronal tissue, living hardware with memory baked in at the cellular level.
• Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.

Portfolio highlights

• Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
• Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
• Dandara Solar Power SAE — Dandara Solar Power SAE is a special purpose vehicle, established to develop a major renewable energy and storage project in Upper Egypt. The entity oversees the development and operational construction of a 500 MW solar PV plant integrated with a 100 MWh Battery Energy Storage System. All electricity generated by the company is bound to be sold to the industrial manufacturer Misr Aluminum Company under a long term, take or pay power purchase agreement.

Portfolio highlights

• Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
• GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
• Polaron — Polaron connects process, structure, and performance using AI and image data to accelerate how materials are characterised, designed, and manufactured.

Portfolio highlights

• UNIVERSAE — UNIVERSAE offers vocational training services.
• Tema Sinergie — Tema Sinergie sviluppa soluzioni avanzate per healthcare, pharma e biotech, integrando tecnologia, precisione, servizio e know-how scientifico.
• Prism Healthcare — Transforming LivesA leading integrated solutions provider dedicated to transforming lives in the paediatric, home, and long-term care sectors. About Prism Healthcare Group Transforming Lives When health or mobility declines, the...

Portfolio highlights

• AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
• NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.

Portfolio highlights

• Monomer Bio — Monomer Bio provides solutions for laboratory automation. We specialize in automating biology research with a focus on cell culture. Automate your cell culture workflows by leveraging the Monomer automation software platform in conjunction with readily-available hardware and instrumentation.
• Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
• Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.

Portfolio highlights

• Kintai — Kintai's a lending platform aiming to help small and medium companies with their funding needs. Based on a merchant cash advance model, companies can return their loans on a daily basis with low frictionless amounts.
• Covides — Covides is a prominent Spanish wine cooperative that integrates grape production, vinification, and international commercial distribution for local winegrowers.
• Flavii Therapeutics — Flavii Therapeutics is a biotechnology company that develops epigenetic therapies for central nervous system disorders with high unmet medical need. Flavii’s lead program, FLVA-27, is a first-in-class small-molecule inhibitor of G9a, a key epigenetic regulator of brain function. FLVA-27 demonstrates exceptional brain penetration, favorable PK/PD properties, and a robust safety profile.

Portfolio highlights

• iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
• Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
• iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.

Portfolio highlights

• Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
• Aino — Aino is a location intelligence tool that enables businesses to analyze spatial data in just minutes. Aino saves hundreds of hours on data work for real estate, retail, urban planning, and geo-marketing companies.
• Orbital Paradigm — Orbital Paradigm builds reusable vehicles that carry cargo to space and bring it back. Dedicated missions, any orbit, on your schedule. Based in Madrid.

Portfolio highlights

• 8Layers — 8Layers is an artificial intelligence platform that offers cloud identity threat detection to organizations
• Artiso — ARTISO AI provides an AI SaaS platform for fashion brands, suppliers, and creative teams. The platform supports concept development, moodboards, design development, placement prints, all-over prints, tech packs, and campaign content. It connects design, production, and marketing activities within one workflow. The service is intended for fashion professionals managing product development and campaign preparation.
• iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.

Portfolio highlights

• Algorized — Algorized develops advanced technologies for human presence detection using UWB Radar.
• Ratio — A new way to finance subscription companies without dilution offering flexibility to help you thrive and compete. Put your recurring revenue to work.
• Scout AI — Scout AI is building the robotic foundation model for defense.

Portfolio highlights

• OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Portfolio highlights

• H2SITE — We provide fully integrated systems to produce on-site high quality hydrogen.
• EPowerlabs — Power electronics & controls for e-mobility and clean energy power management and conversion. EPowerlabs is creating next generation product platforms for automotive powertrain electrification. The company also develop power conversion products for hydrogen production and controls for energy storage systems.
• NX Technologies — Power electronics & controls for e-mobility and clean energy power management and conversion. NX Technologies is creating next generation product platforms for automotive powertrain electrification. The company also develop power conversion products for hydrogen production and controls for energy storage systems.

Portfolio highlights

• Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI

Portfolio highlights

• Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
• Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
• Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.

Portfolio highlights

• LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
• Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
• Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.

Portfolio highlights

• Neuroute —
• Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
• VeriSIM Life — Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational questions and generate actionable insights to guide your next steps.

Portfolio highlights

• Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
• Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
• Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.

Portfolio highlights

• Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
• Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
• CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.

Portfolio highlights

• Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
• Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
• The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.

Portfolio highlights

• enmacc — enmacc, the OTC energy trading platform, offers innovative solutions for efficient trading of energy commodities in today's dynamic market.
• SunRoof — Roof of the future
• Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.

Portfolio highlights

• Pago — Managing and paying utility bills, insurance, mobile top-ups and taxes takes too much time for many households in Europe. Pago simplifies these payments by adding automation where possible, using integrations with billers, insurers and online platforms to dramatically reduce the time needed for all these payments. The service is available in theB2C app called Pago and through B2B integrations by embedding Pago features in partner apps through SDK or API. Pago's services are used by over 500k monthly active users in Romania, Poland and Italy.
• Brainactive — Brainactive is an AI-driven platform that streamlines the access to vital insights used by companies to make sound business decisions, by enabling them to directly interview their current and potential customers, regardless of their expertize in sociology, past experience with market research, size of their team, or their market research budget.Integrated with a pool of 300+ million vetted and engaged consumers around the world, the platform allows companies to get relevant answers to their questions in minutes, with assistance from advanced conversational and generative LLM trained on market research, available along the way.Putting businesses in direct contact with their customers essentially removes the need for any intermediaries in the process and brings the costs and time down to a mere fraction of what traditional market research typically requires. At the same time, companies get to keep sensitive concepts and prototypes tested entirely secured, since no one else is involved, at any stage.
• dotLumen - Empowering the Blind — .lumen builds glasses that help the blind live a better life.

Portfolio highlights

• Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
• Nido — Heating & cooling accounts for nearly half of all energy consumption and 40% of energy-related carbon dioxide emissions. In the EU 65M+ boilers are over their useful life and 95% of them use fossil fuels and these need urgent change.At Nido, we are streamlining heat pump installation in the residential sector, enabling users to transition toclean heating & cooling faster with affordable pricing. We also support installers get the best out of their time by removing time consuming tasks and allowing them to focus on their preferred task - home installations!
• Ocean Ecostructures — We convert maritime infrastructures into 'nature positive' spaces through our multi-technological solution.

Portfolio highlights

• Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).

Portfolio highlights

• Biocellis — Biocellis develops ultra-sensitive, bioluminescence-based diagnostics for next-generation immunoassays. Scalable, fast, and point-of-care ready.
• Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
• Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.

Portfolio highlights

• DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
• AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
• Excelsior Sciences — Rebuilding the World, From the Bottom Up

Portfolio highlights

• ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
• Graviton Bioscience — Curing Disease through Restored Homeostasis
• Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.

Portfolio highlights

• Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
• ABAC Therapeutics — Situs resmi di Indonesia yang menghadirkan game dari PG Soft & Pragmatic Play Paling Gacor , Gampang JP Disini, surga77 memberikan akses ke permainan slot berkualitas tinggi dengan RTP yang terbukti akurat. Semua game yang disediakan di situs ini memiliki tingkat kemenangan yang transparan dan mudah diprediksi. surga77 memastikan bahwa setiap permainan dioperasikan dengan standar tertinggi dalam hal keamanan dan keadilan. Dengan berbagai fitur menarik dan berbagai pilihan permainan, pemain dapat menikmati pengalaman bermain slot yang menyenangkan dan menguntungkan. Ditambah dengan sistem transaksi yang cepat dan layanan pelanggan yang responsif, surga77 adalah tempat yang sempurna untuk para penggemar slot di Indonesia yang ingin bermain dengan nyaman.